Lifeboat Foundation

Closes July 31st at Midnight

The Texas Cyber Summit is a three day multi-track novice to ninja technical cybersecurity event held annually with an expectation of over 1,200 participants in-person. Note that the in-person will take place in September 22nd – 24th, and the Virtual Conference will take place in November 5th. Featuring five dedicated learning tracks for the aspiring Cybersecurity novice to the expert operator. Deeply technical, research and management briefings that address the entire cyber threat landscape. The Texas Cyber Summit is held in Austin, Tx and is a IRS 501C3 Non-Profit Organization.

Austin is home to major fortune 500 companies, Cyber Futures Command, Defense Logistics Agency, and Air force logistics. We host Specialized tracks include teaching, training, responsibilities, and ethics in specialized fields such as digital forensics, Scada, Supply Chain, Red Team Tools, Tactics and Procedures, Blue Team and the Art of Defense, and much more.

The TechCrunch Global Affairs Project examines the increasingly intertwined relationship between the tech sector and global politics.

Geopolitical actors have always used technology to further their goals. Unlike other technologies, artificial intelligence (AI) is far more than a mere tool. We do not want to anthropomorphize AI or suggest that it has intentions of its own. It is not — yet — a moral agent. But it is fast becoming a primary determinant of our collective destiny. We believe that because of AI’s unique characteristics — and its impact on other fields, from biotechnologies to nanotechnologies — it is already threatening the foundations of global peace and security.

The rapid rate of AI technological development, paired with the breadth of new applications (the global AI market size is expected to grow more than ninefold from 2020 to 2028) means AI systems are being widely deployed without sufficient legal oversight or full consideration of their ethical impacts. This gap, often referred to as the pacing problem, has left legislatures and executive branches simply unable to cope.

The battle between artificial intelligence and human intelligence has been going on for a while not and AI is clearly coming very close to beating humans in many areas as of now. Partially due to improvements in neural network hardware and also improvements in machine learning algorithms. This video goes over whether and how humans could soon be surpassed by artificial general intelligence.
–
TIMESTAMPS:
00:00 Is AGI actually possible?
01:11 What is Artificial General Intelligence?
03:34 What are the problems with AGI?
05:43 The Ethics behind Artificial Intelligence.
08:03 Last Words.
–
#ai #agi #robots

Elliot Ackerman is following the crisis in Ukraine closely. The author and former U.S. marine served five tours of duty in Iraq and Afghanistan and has just spent two weeks in Kyiv. Ackerman joins Walter Isaacson to discuss Russia’s new tactics and the role of moral resolve in war.

Originally aired on March 30, 2022

Continue reading “Fmr. Marine Elliot Ackerman: Ukraine Has a Three-to-One Advantage | Amanpour and Company” »

Hello 👋 guys check out our newest video.

#(What)

Continue reading “What Code Of Ethics Must Robots Follow” »

The majority of commercial chemicals that enter the market in the United States every year have insufficient health and safety data. For pesticides, the U.S. Environmental Protection Agency uses a variety of techniques to fill data gaps in order to evaluate chemical hazard, exposure and risk. Nonetheless, public concern over the potential threat that these chemicals pose has grown in recent years, along with the realization that traditional animal-testing methods are not pragmatic by means of speed, economics or ethics. Now, researchers at the George Washington University have developed a new computational approach to rapidly screen pesticides for safety, performance and how long they will endure in the environment. Moreover, and most importantly, the new approach will aid in the design of next-generation molecules to develop safer pesticides.

“In many ways, our tool mimics computational drug discovery, in which vast libraries of chemical compounds are screened for their efficacy and then tweaked to make them even more potent against specific therapeutic targets,” Jakub Kostal, an assistant professor of chemistry at GW and principal investigator on the project, said. “Similarly, we use our systems-based approach to modify pesticides to make them less toxic and more degradable, while, at the same time, making sure they retain good performance. It’s a powerful tool for both industry and regulatory agencies that can help design new, safer analogs of existing commercial agrochemicals, and so protect human life, the environment and industry’s bottom line.”

Using their model, the team analyzed 700 pesticides from the EPA’s pesticide registry. The model considered a pesticide’s likely persistence or degradation in the environment over time, its safety, and how well it performed at killing, repelling or controlling the target problem.

Putin’s war on Ukraine grinds on, into its fourth week. Civilian casualties are mounting, families have been ripped apart, and vast areas are destroyed. President Zelensky says Putin has turned his country’s sky into a source of death. But whether Putin wins or loses, it’s clear there’s no returning to the status quo ante. What will emerge from this crisis in the center of Europe? The fate of democracy is at stake. What can a new world order look like? Scholar and author Francis Fukuyama joins the show to discuss whether the U.S.-led world order can survive — and whether America has the moral authority and the will to lead.

Originally aired on March 18, 2022

Continue reading “Can a U.S.-Led World Order Survive After Ukraine? | Amanpour and Company” »

Public policy includes efforts by governmental as well as nongovernmental agencies (other than professional associations) to manage genetic enhancement. For example, the International Olympic Committee has a policy on performance-enhancing drugs in sport. In the United States, the Food and Drug Administration classified synthetic anabolic steroids as a restricted class of drugs, making it more difficult to get access to them. Such measures will not always be successful. Epoetin alfa (EPO) is a useful medication for the many people who suffer from chronic anemia, including people who must undergo regular renal dialysis. As a consequence, it is in very wide supply for legitimate therapeutic purposes, unlike the synthetic anabolic steroids. Imposing strict limitations on access to EPO would create an enormous inconvenience for the large number of people who benefit from the drug. The fact that some athletes are able to get their hands on EPO is an unintended consequence of having the drug widely available for legitimate therapeutic uses. The appropriate public policy will not be the same, necessarily, for every drug.

By “personal policy” we mean the moral understandings and social practices of individuals, parents, and families, including those moral convictions that would cause them to refrain from unwise or unfair use of genetic enhancement technologies. The Worth of a Child, for example, focuses on ethical issues involving children and parents.¹¹ How does one engage that sort of personal policy response? The means we have are limited but powerful: education, public dialogue, and the encouragement of ethical reflection.

In conclusion, there are four points worth reiterating. First, as we think about genetic enhancement, we should use a broad definition of genetic-enhancement technologies, not merely gene manipulation, but indirect genetic technologies, such as biosynthetic drugs. Second, we should try to anticipate the enhancement temptations of new therapies. Such anticipation may help us in shaping the marketing, availability, or other aspects of those technologies. Third, we should promote the adoption of appropriate public and professional policies. Finally, we should provide public education and dialogue to encourage personal ethical reflection on the appropriate uses and limits of genetic-enhancement technologies.